OOIR: Observatory of International Research

Papers

(The TQCC of Movement Disorders is 9. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)

Article	Citations
In Memoriam Mahlon R. DeLong (1938–2024)	513
John Michael Walshe (April 24, 1920–October 14, 2022)	188
The Emergence and Progression of Motor Dysfunction in Individuals at Risk of Parkinson's Disease	145
Stability of Mosaic Divergent Repeat Interruptions in X‐Linked Dystonia‐Parkinsonism	134
Mortality of People with Parkinson's Disease in a Large UK‐Based Cohort Study: Time Trends and Relationship to Disease Duration	126
	108
YY1: A New Gene for Childhood Onset Dystonia with Prominent Oromandibular‐Laryngeal Involvement?	98
Substantia Nigra Elasticity Measurement Using Transcranial Shear Wave Elastography: A Potential Biomarker for Parkinson's Disease	98
Prevalence of NOTCH2NLC and FMR1 Repeat Expansions in Atypical Parkinsonism Compared to Asymptomatic Elderly Individuals	97
Neuroinflammation in the Cerebellum and Brainstem in Friedreich Ataxia: An [¹⁸F]‐FEMPA PET Study	88
Adaptive Deep Brain Stimulation: From Experimental Evidence Toward Practical Implementation	85
The FDA Has Ended Required Blood Monitoring for Clozapine Use—Will This Impact the Management of Parkinson's Disease Psychosis?	83
Motor Cortex Disinhibition Correlates with Olfactory Dysfunction in Parkinson's Disease	81
The Pattern and Stages of Atrophy in Spinocerebellar Ataxia Type 2: Volumetrics from ENIGMA‐Ataxia	80
Classifying Idiopathic Rapid Eye Movement Sleep Behavior Disorder, Controls, and Mild Parkinson's Disease Using Gait Parameters	77
The Hypoxia Response Pathway: A Potential Intervention Target in Parkinson's Disease?	70
Measuring Tremor—A Comparison of Automated Video Analysis, Neurophysiology, and Clinical Rating	70
X‐Linked Dystonia‐Parkinsonism (“Lubag”) May Present with Peripheral Synucleinopathy	69
Deep Brain Stimulation of the Globus Pallidus Internus and Externus in Multiple System Atrophy	68
Fixel‐Based Analysis Reveals Whole‐Brain White Matter Abnormalities in Cervical Dystonia	68
Bidirectional Transcription at the PPP2R2B Gene Locus in Spinocerebellar Ataxia Type 12	64
Plasma Biomarkers and Positron Emission Tomography Tau Pathology in Progressive Supranuclear Palsy	63
Treatment for Dyskinesia in Parkinson's Disease: A Network Meta‐analysis of Randomized Controlled Trials	63
Early Changes in Striatal Activity and Motor Kinematics in a Huntington's Disease Mouse Model	62
Dual Task Turning in Place: A Reliable, Valid, and Responsive Outcome Measure of Freezing of Gait	61

The Views of Patients with Isolated Rapid Eye Movement Sleep Behavior Disorder on Risk Disclosure	60
A Double‐Blind, Randomized, Placebo‐Controlled Trial of Ursodeoxycholic Acid (UDCA) in Parkinson's Disease	60
α‐Synuclein V15A Variant in Familial Parkinson's Disease Exhibits a Weaker Lipid‐Binding Property	59
Annonaceae Consumption Worsens Disease Severity and Cognitive Deficits in Degenerative Parkinsonism	58
May Infographic	58
Movement Disorders: Volume 40, Number 6, June 2025	57
Movement Disorders: Volume 40, Number 2, February 2025	56
Issue Information	56
Investigation of Shared Genetic Risk Factors Between Parkinson's Disease and Cancers	55
Obituary for Jan O. Aasly (1950–2022)	54
Central Involvement in Pure Autonomic Failure: Insights from Neuromelanin‐Sensitive Magnetic Resonance Imaging and ¹⁸F‐Fluorodopa‐Positron Emission Tomography	52
Author Index	52
Thank you to Reviewers 2022	52
	52
Downbeat Nystagmus in Episodic Ataxia Type 1 Associated with a Novel KCNA1 Mutation	51
Diagnostic and Prognostic Value of External Anal SphincterEMGPatterns in Multiple System Atrophy	50
Effect of Public Interest in Magnetic Resonance Imaging–Guided Focused Ultrasound on Enrolment for Deep Brain Stimulation	50
Reply to: “Application of the mPSPRS to the Salerno Cohort”	49
Cortical Functional Connectivity Changes in the Body‐First and Brain‐First Subtypes of Parkinson's Disease	49
In Vivo Investigation of Glucose Metabolism in Idiopathic and PRKN‐Related Parkinson's Disease	47
Research Priorities on the Role of α‐Synuclein in Parkinson's Disease Pathogenesis	45
	44
Substantiating the Short Burst Duration in Cortical Myoclonus	43
Novel In‐Frame FGF14 Deletion Causes Spinocerebellar Ataxia Type 27A: Clinical Response to Deep Brain Stimulation and 4‐Aminopyridine	43
Functional Movement Disorders and Drug‐Induced Movement Disorders	43
The Lows of High Reward: Choking Under Pressure	43
Genetic Determinants of Survival in Parkinson's Disease in the Asian Population	42
Reply to: “An Exponential Rather Than Multistep Model of Parkinson's Disease Pathogenesis”	42
De Novo and Dominantly Inherited SPTAN1 Mutations Cause Spastic Paraplegia and Cerebellar Ataxia	42
Reply to: “Adult‐Onset Neurodegeneration in Nucleotide Excision Repair Disorders: More Common than Expected”	41
Derivation and Validation of a Phenoconversion‐Related Pattern in Idiopathic Rapid Eye Movement Behavior Disorder	41
Exploration of Neurodegenerative Diseases Using Long‐Read Sequencing and Optical Genome Mapping Technologies	40
Stress in Musicians with and Without Focal Dystonia Is Not Reflected in Limbic Circuit Activation	40
Limbic Serotonergic Plasticity Contributes to the Compensation of Apathy in Early Parkinson's Disease	40
Plant‐Based Dietary Patterns and Parkinson's Disease: A Prospective Analysis of the UK Biobank	39
Combining Skin α‐Synuclein Real‐Time Quaking‐Induced Conversion and Circulating Neurofilament Light Chain to Distinguish Multiple System Atrophy and Parkinson's Disease	38
Parkinson's Disease Phenotypes in Patient Neuronal Cultures and Brain Organoids Improved by 2‐Hydroxypropyl‐β‐Cyclodextrin Treatment	38
Patients with Allan‐Herndon‐Dudley Syndrome (MCT8 Deficiency) Display Symptoms of Parkinsonism in Childhood and Respond to Levodopa/Carbidopa Treatment	38
Movement Disorders: Volume 36, Number 11, November 2021	38
Movement Disorders: Volume 37, Number 9, September 2022	37
October Infographic	37
Issue Information	37
Issue Information	37
Navigating Visual Challenges: How Parkinson's Disease Alters Cognitive Priorities in Visual Search	36
Spinal Cord Stimulation Failed to Improve Parkinson's Disease Symptoms in Randomized Crossover Double‐Blinded Evaluation	36
Parkin Deficiency Impairs Mitochondrial DNA Dynamics and Propagates Inflammation	36
Lesion of the Subthalamic Nucleus Should Not be Labeled “Subthalamotomy”; A Plea for Anatomical Accuracy and Compliance with Historical Legacy	36
Oligodendrocyte and Extracellular Matrix Contributions to Central Nervous System Motor Function: Implications for Dystonia	35
Association between the Amplification Parameters of the α‐Synuclein Seed Amplification Assay and Clinical and Genetic Subtypes of Parkinson's Disease	35
Re‐emergent Tremor in Parkinson's Disease: Evidence of Pathologic β and Prokinetic γ Activity	35

Corrections to “A Machine‐Learning Derived Huntington's Disease Progression Model: Insights for Clinical Trial Design”	35
Parkinson's Disease Modification Through Abl Kinase Inhibition: An Opportunity	35
A Novel SPAST Mutation Results in Spastin Accumulation and Defects in Microtubule Dynamics	34
Tract‐Specific Spinal Cord Diffusion Tensor Imaging in Friedreich's Ataxia	34
Static Posture Instability as a Sensitive Biomarker for Motor Abnormalities in Pre‐ataxic Spinocerebellar Ataxia Type 3 Patients	34
The Self‐Administered Screening Questionnaire for Parkinson's Disease‐Associated Psychosis (SASPAP)	34
Whole‐Brain Magnetic Resonance Spectroscopy Reveals Distinct Alterations in Neurometabolic Profile in Progressive Supranuclear Palsy	34
A PIAS1 Protective Variant S510G Delays polyQ Disease Onset by Modifying Protein Homeostasis	34
Subthalamic Nucleus Activity during Cognitive Load and Gait Dysfunction in Parkinson's Disease	33
Teaching an Old Drug a New Trick for Dystonia	33
In Memoriam Gregor K. Wenning (1964–2024)	33
Genetic Determined Iron Starvation Signature in Friedreich's Ataxia	33
Paroxysmal Kinesigenic Dyskinesia Secondary to Brain Calcification with a Homozygous MYORG Mutation	32
Digging into the Unknowns of the Human Genome Sequence: The T2T‐CHM13 Reference Assembly Release	32
Secondary Paroxysmal Kinesigenic Dyskinesia with a CASR Mutation	32
Ethnic Differences in Dystonia Prevalence and Phenotype	32
Glia Imaging Shows Clinical Utility in Differentiating Parkinson's Disease from Multiple System Atrophy	32
Unusual Age‐Dependent Behavior of Leukocytes Telomere Length in Friedreich's Ataxia	32
Clearing the Smoke: What Protects Smokers from Parkinson's Disease?	31
Mitochondrial DNA Copy Number as a Potential Biomarker for the Severity of Motor Symptoms and Prognosis in Parkinson's Disease	31
Shared Genetics and Comorbid Genes of Amyotrophic Lateral Sclerosis and Parkinson's Disease	31
Classification and Genotype–Phenotype Relationships of GBA1 Variants: MDSGene Systematic Review	31
Juvenile‐Onset Huntington Disease Pathophysiology and Neurodevelopment: A Review	30
Movement Disorders: Volume 40, Number 3, March 2025	30
Essential Tremor Suppression with a Novel Anti‐Tremor Orthosis: A Randomized Crossover Trial	30
Update on Treatments for Parkinson's Disease Motor Fluctuations – An International Parkinson and Movement Disorder Society Evidence‐Based Medicine Review	30
Issue Information	29
Sex and Racial/Ethnic Differences in End‐of‐Life Care Preferences in Persons with Parkinson's Disease and Related Disorders	29
Parkinsonisms	29
February Infographic	29
Issue Information	29
August Infographic	29
Defining the Importance of Minor Hallucinations in Parkinson's Disease	29
Movement Disorders: Volume 38, Number 12, December 2023	29
Low/High Multi‐Frequency Stimulation of the Subthalamic Nucleus Improves Verbal Fluency Maintaining Motor Control in Parkinson's Disease	29
Issue Information	29
Issue Information	29
Chromatic Pupillometry in Isolated Rapid Eye Movement Sleep Behavior Disorder	28
Fatigue in Parkinson's Disease: A Proteomic Study of Cerebrospinal Fluid	28
Epigenetic Drug Effects in Levodopa‐Treated Patients with Parkinson's Disease	28
Pain in Multiple System Atrophy: A Community‐Based Survey	28
Keyword Index	28
Altered Spatiotemporal Dynamics of the Resting Brain in Mild Cognitive Impairment with Lewy Bodies	28
Correction to “Management of Impulse Control and Related Disorders in Parkinson's Disease: An Expert Consensus”	28
Potential Disease‐Modifying Effects of Ganglioside GM1 Pulse Treatment on Spinocerebellar Ataxia Type 3, a Parallel‐Group, Double‐Blind, Randomized, Controlled Trial	27
Placebo and Nocebo Responses in Pharmacological Trials of Tic Disorders: A Meta‐Analysis	27
Free‐Water Imaging in Friedreich Ataxia Using Multi‐Compartment Models	27
Neurodegeneration with Brain Iron Accumulation Disorders and Retinal Neurovascular Structure	27
Selective Effects of Substantia Nigra and Locus Coeruleus Degeneration on Cognition in Parkinson's Disease	27
Reply to: “Early Onset Nonprogressive Generalized Dystonia Is Caused by Biallelic SHQ1 Variants”	27
COVID‐19 Infection Enhances Susceptibility to Oxidative Stress–Induced Parkinsonism	27
¹⁸F‐Florzolotau PET Imaging Unveils Tau Pathology in Dementia with Lewy Bodies	26
Deciphering the Janus‐Faced Nature of the Apolipoprotein Superfamily in Parkinsonian Neurodegeneration: Molecular Crosstalk Between the Astroglial Secretome and Neuronal Homeostasis	26
Practically Defined Off‐State Dyskinesia Following Repeated Intraputamenal Glial Cell Line–Derived Neurotrophic Factor Administration	26
Genotype–Phenotype Correlations for ATX‐TBP (SCA17): MDSGene Systematic Review	26
A Randomized Trial Assessing the Safety, Pharmacokinetics, and Efficacy During Morning Off of AZ‐009	26
Reply to: Enhancing Clarity in Tremor Network Gene Expression Analysis	25
	25
Glycosphingolipid Changes in Plasma in Parkinson's Disease Independent of Glucosylceramide Levels	25
First Evidence for Disease‐Modifying Treatment of SLC20A2‐Related Primary Familial Brain Calcification	25
CAG Repeat Expansion in THAP11 Is Associated with a Novel Spinocerebellar Ataxia	25
Proteomic Profiling in Dystonia: The Next Frontier for Pathophysiology Research and Biomarker Exploration	25
Two London Memorials to “James Parkinson [1755–1824], Esq. Surgeon, Late of Hoxton‐Square”	25
Pandemic Tic‐like Behaviors Following Social Media Consumption	25
The Concept of Motor Reserve in Parkinson's Disease: New Wine in Old Bottles?	25
Familial Cerebellar Ataxia and Amyotrophic Lateral Sclerosis/Frontotemporal Dementia with DAB1 and C9ORF72 Repeat Expansions: An 18‐Year Study	25
Obituary for Professor Hiroshi Shibasaki	24
Longitudinal Clinical and Biological Characteristics in Juvenile‐Onset Huntington's Disease	24
On‐Demand Cueing for Freezing of Gait in Parkinson's Disease: A Randomized Controlled Trial	24
Reply to: No Evidence that Glucosylsphingosine Is a Biomarker for Parkinson Disease	24
Multimodal Analysis of the Visual Pathways in Friedreich's Ataxia Reveals Novel Biomarkers	24
Reply to: Rewiring Brains in Parkinson's Disease: The New Era of Brain Stimulation	24
Where Do Parkinson's Disease Patients Look While Walking?	24
Learning to Have a Long‐Duration Response	23
Harmonizing Genetic Testing for Parkinson's Disease: Results of the PARKNET Multicentric Study	23
Reply to: Heterogeneity of CSF1R‐RD: Genes, Environment, or Both?	23
Serum Neurofilament Light Chain as a Biomarker of Brain Injury in Wilson's Disease: Clinical and Neuroradiological Correlations	23
Differential Synaptic Loss in β‐Amyloid Positive Versus β‐Amyloid Negative Corticobasal Syndrome	23
Using Movement Disorder Society Unified Parkinson's Disease Rating Scale Parts 2 and 3 Simultaneously: Combining the Patient Voice with Clinician Ratings	23
Automated Motor Tic Detection: A Machine Learning Approach	23

Movement Disorders: Volume 39, Number 9, September 2024	22
Expanding the Allelic and Clinical Heterogeneity of Movement Disorders Linked to Defects of Mitochondrial Adenosine Triphosphate Synthase	22
February Infographic	22
Movement Disorders: Volume 38, Number 9, September 2023	22
Investigating the Brain Mechanisms of Externally Cued Sit‐to‐Stand Movement in Parkinson's Disease	22
GNAO1 Haploinsufficiency: The Milder End of the GNAO1 Phenotypic Spectrum	22
Diffusion Tensor Imaging‐Along the Perivascular‐Space Index Is Associated with Disease Progression in Parkinson's Disease	22
Early‐Onset Movement Disorder Syndrome Caused by Biallelic Variants in PDE1B Encoding Phosphodiesterase 1B	22
No Correlation between Plasma GPNMB Levels and Multiple System Atrophy in Chinese Cohorts	22
Cellular Prion Protein Mediates α‐Synuclein Uptake, Localization, and Toxicity In Vitro and In Vivo	22
Reply to: “Refutation of the αSyn‐SAA‐Based Staging for Parkinson's Progression (Neuronal α‐Synuclein Disease‐Integrated Staging System [NSD‐ISS])”	22
Elevated Urinary Rab10 Phosphorylation in Idiopathic Parkinson Disease	22
Plasma Phosphorylated Tau181 as a Biomarker for Alzheimer's Disease Co‐Pathology in Lewy Body Disease	22
Issue Information	21
	21
Molecular Features of Parkinson's Disease in Patient‐Derived Midbrain Dopaminergic Neurons	21
Dairy Intake and Parkinson's Disease: A Mendelian Randomization Study	21
Long‐Term Nicotinamide Riboside Use Improves Coordination and Eye Movements in Ataxia Telangiectasia	21
Keyword Index	21
mTOR Inhibition with Sirolimus in Multiple System Atrophy: A Randomized, Double‐Blind, Placebo‐Controlled Futility Trial and 1‐Year Biomarker Longitudinal Analysis	21
	21
Discussion of Research Priorities for Gait Disorders in Parkinson's Disease	21
A Short Progressive Supranuclear Palsy Quality of Life Scale: Data from the PSP‐NET	21
Brain Dynamics Complexity as a Signature of Cognitive Decline in Parkinson's Disease	21
Movement Disorders: Volume 38, Number 11, November 2023	20
April Infographic	20
Automated Quantification of Eye Tics Using Computer Vision and Deep Learning Techniques	20
Parkin Maintains Robust Pacemaking in Human Induced Pluripotent Stem Cell‐Derived A9 Dopaminergic Neurons	20
Diagnosis and Outcomes of Late‐Onset Wilson's Disease: A National Registry‐Based Study	20
March Infographic	20
Erythrocytic α‐Synuclein and the Gut Microbiome: Kindling of the Gut‐Brain Axis in Parkinson's Disease	20
Issue Information	20
Brain Imaging Phenotypes Associated with Polygenic Risk for Essential Tremor	20
Pathophysiological Role of Primary Motor Cortex in Essential Tremor	20
Anodal Cerebellar Transcranial Direct Current Stimulation Reduces Motor and Cognitive Symptoms in Friedreich's Ataxia: A Randomized, Sham‐Controlled Trial	20
Reply to Letter to the Editor‐MDS‐23‐0498.R2/MDS‐24‐0318.R1	19
Comparative Study of Focused Ultrasound Unilateral Thalamotomy and Subthalamotomy for Medication‐Refractory Parkinson's Disease Tremor	19
The Pain in Dystonia Scale (PIDS)—Development and Validation in Cervical Dystonia	19
Step Width Haptic Feedback for Gait Stability in Spinocerebellar Ataxia: Preliminary Results	19
Family History for Neurodegeneration in Multiple System Atrophy: Does it Indicate Susceptibility?	19
Deep Brain Stimulation Improves Parkinson's Disease‐Associated Pain by Decreasing Spinal Nociception	19
Bidirectional Interplay between Deep Brain Stimulation and Cognition in Parkinson's Disease: A Systematic Review	19
Endoscopic Characteristics of Dysphagia in Multiple System Atrophy Compared to Parkinson's Disease	19
Re‐Analysis of the STEADY‐PD II Trial—Evidence for Slowing the Progression of Parkinson's Disease	19
Prasinezumab: A Bayesian Perspective on Its Efficacy	19
Blood‐Based α‐Synuclein Seeding—A New Era for Identifying Parkinsonian Syndromes	19
Mendelian Randomization Studies: A Path to Better Understand Sex and Gender Differences in Parkinson's Disease?	19
Erythropoietin in Spinocerebellar Ataxia Type 2: Feasibility and Proof‐of‐Principle Issues from a Randomized Controlled Study	19
Cerebellar Volume and Disease Staging in Parkinson's Disease: An ENIGMA‐PD Study	19
Striatal Cholinergic Dysregulation after Neonatal Decrease in X‐Linked Dystonia Parkinsonism‐Related TAF1 Isoforms	19
Mutation Screening of TFG in α‐Synucleinopathy and Amyotrophic Lateral Sclerosis	19
Circulating Extracellular Vesicles as a Potential Mediator of Synuclein Pathology in the Gut	19
Catatonia: What Else Matters?	18
	18
Clinical Utility of Neurophysiologic Classification (and Declassification) of Myoclonus	18
	18
Autosomal Recessive Cerebellar Ataxias in Europe: Frequency, Onset, and Severity in 677 Patients	18
A GNAI1 Pathogenic Variant in a Case with GNAO1‐Isolated Dystonia: A Modifier of Disease Severity?	18
Depressive Symptoms and Suicidal Thoughts in Restless Legs Syndrome	18
Surgery Imaging and Technology	18
Genetic Analysis of GCA Repeats in the GLS Gene: Implications for Undiagnosed Ataxia and Spinocerebellar Ataxia 3 in Mainland China	18
Dysautonomia Is Associated with Cognitive Fluctuation in Dementia with Lewy Bodies	17
An Exponential Rather Than Multistep Model of Parkinson's Disease Pathogenesis	17
Shaking Up Ataxia: FGF14 and RFC1 Repeat Expansions in Affected and Unaffected Members of a Chilean Family	17
Globus Pallidus Internus (GPi) Neuromodulation is Not Effective in Unverricht–Lundborg Disease to Control Myoclonia	17
Deep Brain Stimulation as an Exclusion Criterion in Parkinson's Disease Studies: Time to Rethink?	17
Disentangling the Connection Between Neurodevelopment and Neurodegeneration in Huntington's Disease	17
Advancing Parkinson's Research: Considerations and Future Directions	17
Differences in Sex‐Specific Frequency of Glucocerebrosidase Variant Carriers and Familial Parkinsonism	17
Impact of Magnetic Resonance Imaging Markers on the Diagnostic Performance of the International Parkinson and Movement Disorder Society Multiple System Atrophy Criteria	17
The Dawn of Precision Medicine for Deep Brain Stimulation in Parkinson's Disease?	17
A 10‐Year Community‐Based Study of Leucine‐Rich Repeat Kinase 2 G2385R Carriers' Conversion to Parkinson's Disease	17
Magnetic Susceptibility in Progressive Supranuclear Palsy Variants, Parkinson's Disease, and Corticobasal Syndrome	16
Beta Burst Characteristics and Coupling within the Sensorimotor Cortical‐Subthalamic Nucleus Circuit Dynamically Relate to Bradykinesia in Parkinson's Disease	16
Further Directions in Mindfulness‐Based Interventions for Tic Disorders	16
Viewpoint on Milestones for Fellowship Training in Movement Disorders	16
Computerized Cognitive Training Increases Gray Matter Volumes in Huntington's Disease: A Pilot Study	16
Diffusion Magnetic Resonance Imaging Microstructural Abnormalities in Multiple System Atrophy: A Comprehensive Review	16
Bilateral Simultaneous Magnetic Resonance–Guided Focused Ultrasound Pallidotomy for Life‐Threatening Status Dystonicus	16
Putaminal Recombinant Glucocerebrosidase Delivery with Magnetic Resonance–Guided Focused Ultrasound in Parkinson's Disease: A Phase I Study	16
Movement Disorders: Volume 36, Number 10, October 2021	16
Brain and Cerebrospinal Fluid α‐Synuclein Real‐Time Quaking‐Induced Conversion Identifies Lewy Body Pathology in LRRK2‐PD	16
No Association Between Rare TWNK Variants and Parkinson's Disease in European Cohorts	16
Neurodevelopmental Gene‐Related Dystonia‐Parkinsonism with Onset in Adults: A Case with NAA15 Variant	16
IRF2BPL‐Related Disorder, Causing Neurodevelopmental Disorder with Regression, Abnormal Movements, Loss of Speech and Seizures (NEDAMSS) Is Characterized by Pathology Consistent	16
Cross‐Ethnic Variant Screening and Burden Analysis of PTPA in Parkinson's Disease	16
Redefining Bradykinesia	16
Motor Cortical Network Excitability in Parkinson's Disease	16
Issue Information	16
Reply to: Comment on De Giorgis et al. “Randomized Phase 3 Study of Triheptanoin for Glut1 Deficiency Syndrome–Associated Paroxysmal Movement Disorders”	16
Reply to: “A Primary Writing Tremor Is a Form of Dystonic Tremor: Is the Debate Settled?”	16
High Pesticide Exposure Events and Dream‐Enacting Behaviors Among US Farmers	16
Aggregation‐Seeding Forms of α‐Synuclein Are Not Detected in Acute Coronavirus Disease 2019 Cerebrospinal Fluid	16
Reliability of Neuroimaging and Neurophysiological Tremor Features in Parkinson's Disease	16
Pilot Study of Acute Behavioral Effects of Pallidal Burst Stimulation in Parkinson's Disease	16